✦ LIBER ✦

Efficacy of an analysis of lymphocyte subsets in predicting the clinical response to α-interferon therapy in thalassaemia patients with chronic infection by hepatitis C virus: a pilot study

✍ Scribed by Giovanna Russo-Mancuso; Felicia Di Gregorio; Enrica Passero; Antonella Sciotto; Maria Clorinda Mazzarino; Grazia Malaponte; Gino Schilirog

Book ID: 114714035
Publisher: John Wiley and Sons
Year: 1995
Tongue: English
Weight: 726 KB
Volume: 89
Category: Article
ISSN: 0007-1048
DOI: 10.1111/j.1365-2141.1995.tb03303.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Time course of histological changes in p

Time course of histological changes in patients with a sustained biochemical and virological response to interferon-α therapy for chronic hepatitis C virus infection

✍ Akihito Tsubota; Hiromitsu Kumada; Kazuaki Chayama; Yasuji Arase; Satoshi Saitoh 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 895 KB

Usefulness of simple assays for serum co

Usefulness of simple assays for serum concentration of hepatitis C virus RNA and HCV genotype in predicting the response of patients with chronic hepatitis C to interferon α2a therapy

✍ Toshio Suzuki; Eiji Tanaka; Akihiro Matsumoto; Akihiko Urushihara; Takeshi Sodey 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 781 KB

## Abstract The use of two new assays was evaluated for predicting the response to interferon (IFN) therapy in patients with chronic hepatitis C. The genotype of hepatitis C virus (HCV) was establishe by an enzyme‐linked immunosorbent assay based on genotype‐specific recombinant peptides of the NS4

Types of human leukocyte antigen and dec

Types of human leukocyte antigen and decrease in HCV core antigen in serum for predicting efficacy of interferon-Α in patients with chronic hepatitis C: analysis by a prospective study

✍ Hidetomo Muto; Eiji Tanaka; Akihiro Matsumoto; Kaname Yoshizawa; Kendo Kiyosawa; 📂 Article 📅 2004 🏛 Springer Japan 🌐 English ⚖ 220 KB

A mutation in the interferon sensitivity

A mutation in the interferon sensitivity-determining region is associated with responsiveness to interferon-ribavirin combination therapy in chronic hepatitis patients infected with a Japan-specific subtype of hepatitis C virus genotype 1b

✍ Mutsumi Murayama; Yoshiaki Katano; Isao Nakano; Masatoshi Ishigami; Kazuhiko Hay 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 178 KB 👁 2 views

## Abstract The interferon sensitivity‐determining region (ISDR) is useful as a predictive marker of the response to interferon (IFN) therapy for chronic hepatitis patients with a Japan‐specific subtype (J‐type) of hepatitis C virus (HCV) genotype 1b. This marker is not useful for predicting respon

Efficacy and Tolerability of Combination

Efficacy and Tolerability of Combination Therapy with Interferon-Alfa Plus Ribavirin in Patients with Chronic Hepatitis C Virus Infection: A Single-Center Study in Relapsers and Nonresponders to Previous Treatment with High-Dose Interferon-Alfa Monotherapy

✍ Federica Benini; Luciana Distefano; Ornella Baisini; Marie Graciella Pigozzi; Al 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 108 KB

Comparison of serum hepatitis C virus RN

Comparison of serum hepatitis C virus RNA concentration by branched DNA probe assay with competitive reverse transcription polymerase chain reaction as a predictor of response to interferon-α therapy in chronic hepatitis C patients

✍ Toyoda, Hidenori; Nakano, Satoshi; Kumada, Takashi; Takeda, Isao; Sugiyama, Keii 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 541 KB

A study was carried out to assess the correlation between the serum concentration of hepatitis C virus RNA (HCV-RNA) in patients with chronic hepatitis, as measured by competitive reverse transcription polymerase chain reaction (cRT-PCR) and branched DNA probe assay (bDNA), and response to interfero